Publications by authors named "Weiming You"

Claim this Profile
A
A bifunctional peptide-selenium nanocomposite for lysosomal degradation of PD-L1 and enhanced cancer immunotherapy.
Yang Wang, Jun Feng, Jin Yan, Weiming You, Siqi Yan

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selenium nanoparticle-delivered MDM2 inhibitor reactivates p53 and reprograms tumor immune microenvironment in colorectal cancer.
Weiming You, Jun Feng, Litao Guo, Jin Yan, Siqi Yan

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-targeted N-PMI@CA nanoplatform for concurrent MDM2 and β-catenin inhibition in p53 wild-type lung adenocarcinoma.
Ni Zhao, Weiming You, Xiaoqiang Zheng, Jin Yan, Peili Wang

Mater Today Bio· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bringing p53 Back: A Prion-Powered Attack on Retinoblastoma.
Yuyan Ma, Siqi Yan, Weiming You, Peili Wang, Wangxiao He

Int J Biol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bionic Power Play: Dual-Targeting MDMX/MDM2 to Reboot p53 to Beat Lung Adenocarcinoma's Immune Tricks.
Solomon Wong, Lu Xu, Weiming You, Wangxiao He, Xiaoqiang Zheng

Int J Nanomedicine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disrupting β-Catenin/BCL9 interaction with a peptide prodrug boosts immunotherapy in colorectal cancer.
Peili Wang, Xiao Shang, Jinmei Wang, Weiming You, Shoufei Qu

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting enabled homolog with daunorubicin inhibits ERK1/2/c-Fos pathway and suppresses hepatocellular carcinoma progression.
Zhi-Mei Li, Guan Liu, Qing-Qing Liu, Wei-Ming You, Ming-Gao Zhao

Clin Transl Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence-Guided Cancer Engineering for Tumor Normalization Executed by Tumor Lysosomal-Triggered Supramolecular Chiral Peptide.
Jingmei Wang, Weiming You, Wangxiao He, Jin Yan, Yanmin Zhang

ACS Nano· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Carnosic acid nanocluster-based framework combined with PD-1 inhibitors impeded tumorigenesis and enhanced immunotherapy in hepatocellular carcinoma.
Wenhua Wu, Yaping Li, Xiaokang Wu, Junrong Liang, Weiming You

Funct Integr Genomics· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resurrecting p53 by an Artificial Nano-Protein for Potent Photodynamic Retinoblastoma Therapy.
Siqi Yan, Wenguang Yang, Weiming You, Wangxiao He, Jin Yan

Small· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Transdermal Prion-Bionics Supermolecule as a RAB3A Antagonist for Enhancing Facial Youthfulness.
Wenjia Liu, Fan Ding, Wenguang Yang, Weiming You, Liqiang Zhang

Adv Sci (Weinh)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rewiring chaperone-mediated autophagy in cancer by a prion-like chemical inducer of proximity to counteract adaptive immune resistance.
Jin Yan, Dan Liu, Jingmei Wang, Weiming You, Wenguang Yang

Drug Resist Updat· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carnosic acid nanocluster-based framework combined with PD-1 inhibitors impeded tumorigenesis and enhanced immunotherapy in hepatocellular carcinoma.
Wenhua Wu, Yaping Li, Xiaokang Wu, Junrong Liang, Weiming You

Funct Integr Genomics· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A d-peptide-based oral nanotherapeutic modulates the PD-1/PD-L1 interaction for tumor immunotherapy.
Dan Liu, Jingmei Wang, Weiming You, Fang Ma, Qi Sun

Front Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vps21 Directs the PI3K-PI(3)P-Atg21-Atg16 Module to Phagophores via Vps8 for Autophagy.
Lei Zhao, Weiming You, Dan Sun, Hui Xu, Xia You

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis.
Weinan Guo, Zhenjie Wu, Jianru Chen, Sen Guo, Weiming You

J Immunother Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Turning a Targeting β-Catenin/Bcl9 Peptide Inhibitor into a GdOF@Au Core/Shell Nanoflower for Enhancing Immune Response to Cancer Therapy in Combination with Immune Checkpoint Inhibitors.
Weiming You, Fang Ma, Zhang Zhang, Jin Yan

Pharmaceutics· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bionic-Homodimerization Strategy for Optimizing Modulators of Protein-Protein Interactions: From Statistical Mechanics Theory to Potential Clinical Translation.
Jin Yan, Xiaoqiang Zheng, Weiming You, Wangxiao He, Guang-Kui Xu

Adv Sci (Weinh)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Turing milk into pro-apoptotic oral nanotherapeutic: bionic chiral-peptide supramolecule for cancer targeted and immunological therapy.
Wangxiao He, Zhang Zhang, Wenguang Yang, Xiaoqiang Zheng, Weiming You

Theranostics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: A general-purpose Nanohybrid fabricated by Polymeric Au(I)-peptide precursor to wake the function of Peptide Therapeutics: Erratum.
Jin Yan, Fanpu Ji, Siqi Yan, Weiming You, Fang Ma

Theranostics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Tumor-Targeting Metal-Organic Nanoparticle Constructed by Dynamic Combinatorial Chemistry toward Accurately Redressing Carcinogenic Wnt Cascade.
Tianya Liu, Jin Yan, Chenchen He, Weiming You, Fang Ma

Small· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Turing miRNA into infinite coordination supermolecule: a general and enabling nanoengineering strategy for resurrecting nuclear acid therapeutics.
Liya Li, Wangxiao He, Weiming You, Jin Yan, Wenjia Liu

J Nanobiotechnology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assembling BH3-mimic peptide into a nanocluster to target intracellular Bcl2 towards the apoptosis induction of cancer cell.
Xiuli Zhang, Ruqing Gao, Huiyu Yan, Zijian Zhao, Jun Zhang, Weiming You

Nanotechnology· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity.
Siqi Yan, Jin Yan, Dan Liu, Xiang Li, Qianyan Kang, Weiming You

Theranostics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De Novo Nano-Erythrocyte Structurally Braced by Biomimetic Au(I)-peptide Skeleton for MDM2/MDMX Predation toward Augmented Pulmonary Adenocarcinoma Immunotherapy.
Xiaoqiang Zheng, Jin Yan, Weiming You, Fanni Li, Jiajie Diao

Small· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis